文献速递青光眼眼底病与葡萄膜炎

健康眼与青光眼眼视盘周围脉络膜变薄的纵向分析

A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects.
PubMed 文献 · Am J Ophthalmol · 2017-12-19

本研究为队列研究,纳入非洲裔青光眼评估研究(ADAGES)与青光眼诊断创新研究(DIGS)多中心受试者共297只眼,中位随访2.6年,用San Diego自动分割算法测量视盘周围脉络膜厚度(PCT)。结果显示健康眼与青光眼眼的PCT年变化率无显著差异(P=.28),百分变化率亦无显著差异(P=.23)。结论认为在该相对较短随访期内两组PCT变薄速率无显著差异,需更长随访判断监测PCT变化在青光眼管理中的作用。

要点

  • 基线全局平均PCT青光眼组141.7±66.3μm vs 健康对照组155.7±64.8μm(P<.001),纳入年龄后差异不再显著(P=.38)。
  • 健康对照组PCT年均变化-2.18μm/年(95%CI -2.97至-1.40),青光眼组-1.88μm/年(95%CI -3.08至-0.67)。
  • 两组PCT年均变化率(P=.28)与百分变化率(P=.23)均无显著差异。

核心结论

  • 在该相对较短随访期内,健康眼与青光眼眼的视盘周围脉络膜变薄速率无显著差异。
  • 需要更长随访以确定监测PCT变化率在青光眼管理中是否有作用。

研究设计与样本

  • 队列研究,受试者来自多中心非洲裔青光眼评估研究(ADAGES)与青光眼诊断创新研究(DIGS)。
  • 采用San Diego自动分割算法从以视神经乳头为中心的环形扫描自动分割并测量视盘周围脉络膜厚度(PCT)。
  • 使用混合效应模型计算PCT变薄速率;共纳入297只眼,中位随访2.6年。

主要发现

  • 基线全局平均PCT青光眼组141.7±66.3μm vs 健康对照组155.7±64.8μm(P<.001),纳入年龄后差异不再显著(P=.38)。
  • 健康对照组平均PCT变化-2.18μm/年(95%CI -2.97至-1.40),青光眼组-1.88μm/年(95%CI -3.08至-0.67)。
  • 健康对照组平均PCT百分变化-3.32%/年(95%CI -4.36至-2.27),青光眼组-2.85%/年(95%CI -4.64至-0.99)。
  • 健康对照组与青光眼组平均PCT变化率无显著差异(P=.28),PCT百分变化率亦无显著差异(P=.23)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出随访期相对较短。
  • 原文结论提出需要更长随访以确定监测PCT变化率在青光眼管理中是否有作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the rate of peripapillary choroidal thinning in glaucoma patients and healthy controls using spectral domain optical coherence tomography. DESIGN: Cohort study. METHODS: Participants from the multicenter African Descent and Glaucoma Evaluation Study and Diagnostic Innovations in Glaucoma Study were included. The San Diego Automated Segmentation Algorithm was used to automatically segment and measure peripapillary choroidal thickness (PCT) from circle scans centered on the optic nerve head. The rate of PCT thinning was calculated using mixed effects models. RESULTS: Two hundred ninety-seven eyes with a median follow-up of 2.6 years were included. At baseline, the global mean PCT was significantly thinner in glaucoma patients than healthy control subjects (141.7 ± 66.3 μm vs 155.7 ± 64.8 μm, respectively; P < .001). However, when age was included in the model, this difference was no longer significant (P = .38). Both healthy controls and glaucoma patients had a significant decrease in mean (95% confidence interval) PCT change over time (-2.18 [-2.97 to -1.40 μm/year] and -1.88 [-3.08 to -0.67 μm/year], respectively) and mean PCT percent change over time (-3.32% [-4.36 to -2.27 μm/year] and -2.85% [-4.64 to -0.99 μm/year], respectively). No significant difference was found between healthy control subjects and glaucoma patients in the mean rate of PCT change (P = .28) or PCT percentage change over time (P = .23). CONCLUSIONS: The rate of peripapillary choroidal thinning was not significantly different between healthy and glaucoma eyes during this relatively short follow-up period. Longer follow-up is needed to determine whether monitoring the rate of PCT change has a role in glaucoma management.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Mundae RS, Zangwill LM, Kabbara SW, et al. A Longitudinal Analysis of Peripapillary Choroidal Thinning in Healthy and Glaucoma Subjects. Am J Ophthalmol. 2017. PMID: 29103960. doi:10.1016/j.ajo.2017.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。